![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 28, 25862-25870, July 13, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Institute of Pharmacology and Toxicology, University of
Lausanne, 27 Rue du Bugnon, 1005 Lausanne, Switzerland
In the pathogenesis of type I diabetes mellitus,
activated leukocytes infiltrate pancreatic islets and induce
SOCS-1 Protein Prevents Janus
Kinase/STAT-dependent Inhibition of
Cell Insulin
Gene Transcription and Secretion in Response to Interferon-
*
,
,
cell
dysfunction and destruction. Interferon (IFN)-
, tumor
necrosis factor-
and interleukin (IL)-1
play important, although
not completely defined, roles in these mechanisms. Here, using the
highly differentiated
Tc-Tet insulin-secreting cell line, we showed
that IFN-
dose- and time-dependently suppressed insulin
synthesis and glucose-stimulated secretion. As described previously
IFN-
, in combination with IL-1
, also induces inducible NO
synthase expression and apoptosis (Dupraz, P., Cottet, S., Hamburger,
F., Dolci, W., Felley-Bosco, E., and Thorens, B. (2000) J. Biol. Chem. 275, 37672-37678). To assess the role of the Janus
kinase/signal transducer and activator of transcription (STAT) pathway
in IFN-
intracellular signaling, we stably overexpressed SOCS-1
(suppressor of cytokine
signaling-1) in the
cell line. We
demonstrated that SOCS-1 suppressed cytokine-induced STAT-1
phosphorylation and increased cellular accumulation. This was
accompanied by a suppression of the effect of IFN-
on: (i) reduction
in insulin promoter-luciferase reporter gene transcription, (ii)
decrease in insulin mRNA and peptide content, and (iii) suppression of glucose-stimulated insulin secretion. Furthermore, SOCS-1 also suppressed the cellular effects that require the combined presence of
IL-1
and IFN-
: induction of nitric oxide production and
apoptosis. Together our data demonstrate that IFN-
is responsible
for the cytokine-induced defect in insulin gene expression and
secretion and that this effect can be completely blocked by
constitutive inhibition of the Janus kinase/STAT pathway.
*
This work was supported by Juvenile Diabetes Foundation
International Grant 4-1999-844 and by Grant 31-46958.96 from the Swiss National Science Foundation (to B. T.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
These authors contributed equally to this work.
§
To whom correspondence should be addressed: Inst. of Pharmacology
and Toxicology, University of Lausanne, 27 rue du Bugnon, 1005 Lausanne, Switzerland. Tel.: 41-21-692-53-90; Fax:
41-21-692-53-55; E-mail: bthorens@ipharm.unil.ch.
This article has been cited by other articles:
![]() |
S. Klinger, C. Poussin, M.-B. Debril, W. Dolci, P. A. Halban, and B. Thorens Increasing GLP-1-Induced {beta}-Cell Proliferation by Silencing the Negative Regulators of Signaling cAMP Response Element Modulator-{alpha} and DUSP14 Diabetes, March 1, 2008; 57(3): 584 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tang, P. Han, A. I. Oprescu, S. C. Lee, A. V. Gyulkhandanyan, G. N.Y. Chan, M. B. Wheeler, and A. Giacca Evidence for a Role of Superoxide Generation in Glucose-Induced {beta}-Cell Dysfunction In Vivo Diabetes, November 1, 2007; 56(11): 2722 - 2731. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Ronn, N. Billestrup, and T. Mandrup-Poulsen Diabetes and Suppressors of Cytokine Signaling Proteins Diabetes, February 1, 2007; 56(2): 541 - 548. [Full Text] [PDF] |
||||
![]() |
J. A. Emamaullee, R. V. Rajotte, P. Liston, R. G. Korneluk, J. R.T. Lakey, A.M. J. Shapiro, and J. F. Elliott XIAP Overexpression in Human Islets Prevents Early Posttransplant Apoptosis and Reduces the Islet Mass Needed to Treat Diabetes Diabetes, September 1, 2005; 54(9): 2541 - 2548. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Santangelo, A. Scipioni, L. Marselli, P. Marchetti, and F. Dotta Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines Eur. J. Endocrinol., March 1, 2005; 152(3): 485 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsuda, K. Ferreri, I. Todorov, Y. Kuroda, C. V. Smith, F. Kandeel, and Y. Mullen Silymarin Protects Pancreatic {beta}-Cells against Cytokine-Mediated Toxicity: Implication of c-Jun NH2-Terminal Kinase and Janus Kinase/Signal Transducer and Activator of Transcription Pathways Endocrinology, January 1, 2005; 146(1): 175 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Flodstrom-Tullberg, D. Yadav, R. Hagerkvist, D. Tsai, P. Secrest, A. Stotland, and N. Sarvetnick Target Cell Expression of Suppressor of Cytokine Signaling-1 Prevents Diabetes in the NOD Mouse Diabetes, November 1, 2003; 52(11): 2696 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Scarim, S. Y. Nishimoto, S. M. Weber, and J. A. Corbett Role for c-Jun N-Terminal Kinase in {beta}-Cell Recovery from Nitric Oxide-Mediated Damage Endocrinology, August 1, 2003; 144(8): 3415 - 3422. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Tran, G. Chen, C. B. Newgard, and H. E. Hohmeier Discrete and Complementary Mechanisms of Protection of {beta}-Cells Against Cytokine-Induced and Oxidative Damage Achieved by bcl-2 Overexpression and a Cytokine Selection Strategy Diabetes, June 1, 2003; 52(6): 1423 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Federici, M. L. Giustizieri, C. Scarponi, G. Girolomoni, and C. Albanesi Impaired IFN-{gamma}-Dependent Inflammatory Responses in Human Keratinocytes Overexpressing the Suppressor of Cytokine Signaling 1 J. Immunol., July 1, 2002; 169(1): 434 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cottet, P. Dupraz, F. Hamburger, W. Dolci, M. Jaquet, and B. Thorens cFLIP Protein Prevents Tumor Necrosis Factor-{alpha}-Mediated Induction of Caspase-8-Dependent Apoptosis in Insulin-Secreting {beta}Tc-Tet Cells Diabetes, June 1, 2002; 51(6): 1805 - 1814. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M.W. Chong, H. E. Thomas, and T. W.H. Kay {gamma}-Interferon Signaling in Pancreatic {beta}-Cells Is Persistent but Can Be Terminated by Overexpression of Suppressor of Cytokine Signaling-1 Diabetes, December 1, 2001; 50(12): 2744 - 2751. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. THORENS, P. DUPRAZ, and S. COTTET Engineering Tolerance into Transplanted {beta} Cell Lines Ann. N.Y. Acad. Sci., November 1, 2001; 944(1): 267 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Cardozo, H. Heimberg, Y. Heremans, R. Leeman, B. Kutlu, M. Kruhoffer, T. Orntoft, and D. L. Eizirik A Comprehensive Analysis of Cytokine-induced and Nuclear Factor-kappa B-dependent Genes in Primary Rat Pancreatic beta -Cells J. Biol. Chem., December 21, 2001; 276(52): 48879 - 48886. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |